Production (Stage)
Esperion Therapeutics, Inc.
ESPR
$1.17
-$0.03-2.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.41% | 76.01% | 26.02% | 36.71% | 39.59% |
| Total Receivables | 48.86% | 65.26% | 59.13% | 47.94% | 49.97% |
| Inventory | 35.88% | 43.99% | 55.73% | 84.93% | 85.75% |
| Prepaid Expenses | 108.41% | 295.83% | 59.73% | 52.86% | -9.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.81% | 68.10% | 40.93% | 48.67% | 45.89% |
|
|
|||||
| Total Current Assets | -12.81% | 68.10% | 40.93% | 48.67% | 45.89% |
| Net Property, Plant & Equipment | -29.78% | 23.36% | 115.19% | 192.64% | 538.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -13.14% | 67.07% | 41.94% | 50.16% | 48.15% |
|
|
|||||
| Total Accounts Payable | 153.21% | 62.84% | 33.00% | 94.11% | 66.62% |
| Total Accrued Expenses | -9.51% | -13.40% | 0.24% | 45.02% | 47.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 149.28% | 188.34% | 8.45% | 50.97% | 69.05% |
| Total Finance Division Other Current Liabilities | -5.20% | 8.99% | 31.98% | 60.90% | 90.82% |
| Total Other Current Liabilities | -5.20% | 8.99% | 31.98% | 60.90% | 90.82% |
| Total Current Liabilities | 64.71% | 57.62% | 20.45% | 63.60% | 72.29% |
|
|
|||||
| Total Current Liabilities | 64.71% | 57.62% | 20.45% | 63.60% | 72.29% |
| Long-Term Debt | -4.24% | -3.55% | 4.80% | 3.92% | 2.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -55.34% | -14.90% | 61.01% | 133.76% | 464.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.42% | 10.86% | 8.40% | 14.83% | 14.77% |
|
|
|||||
| Common Stock & APIC | 1.71% | 10.27% | 11.12% | 11.13% | 10.81% |
| Retained Earnings | -10.30% | -3.34% | -5.81% | -6.78% | -6.17% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -44.82% | 14.57% | 9.71% | 7.46% | 10.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -44.82% | 14.57% | 9.71% | 7.46% | 10.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -44.82% | 14.57% | 9.71% | 7.46% | 10.73% |
|
|
|||||